相关实验视频
Updated: Jul 17, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
在头部创伤后,大脑中的β A4粉样蛋白沉积
G W Roberts1, S M Gentleman, A Lynch
1Department of Anatomy, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.
Lancet (London, England)
|December 7, 1991
概括
严重的头部损伤可以迅速触发大脑中的β A4粉样蛋白沉积. 这项研究发现38%的患者在头部创伤几天内发现了广泛的β A4粉样蛋白斑块.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 创伤性脑损伤 创伤性脑损伤
背景情况:
- 以前的研究将头部创伤与长期幸存者的β A4粉样蛋白斑块联系起来.
- 人们对头部损伤对粉样蛋白沉积的急性影响不太了解.
研究的目的:
- 调查严重头部损伤诱导βA4粉样蛋白快速沉积的可能性.
- 为了检查头部创伤的短期幸存者的粉样斑块形成.
主要方法:
- 研究了16名头部严重受伤的患者 (年龄在10-63岁之间),他们存活了6-18天.
- 使用了针对β A4粉样蛋白特异性抗体的免疫染.
主要成果:
- 在16名患者中有6名 (38%) 的大脑皮层中观察到大量的βA4粉样蛋白沉积物.
- 这些发现表明,严重头部损伤后粉样蛋白沉积迅速.
结论:
- 严重的头部损伤可以在几天内在大脑中启动βA4粉样蛋白沉积.
- 这表明一种潜在的机制将急性脑创伤与早期神经病理变化联系起来.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

